open access
Self-reported questionnaires for a comprehensive assessment of patients after acute coronary syndrome
Affiliations- Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland
open access
Abstract
Effective patients’ preparation for discharge is expected to improve adherence to long-term treatment and
functioning in chronic faze of coronary artery disease-ameliorating clinical outcome. This paper is aimed to
introduce the strategy of comprehensive post-ACS in-hospital patients’ evaluation regarding readiness for
hospital discharge, as well as a post-discharge assessment of adherence to pharmacological treatment and
functioning in the chronic phase of the coronary artery. A system of diagnostic tools allowing assessment
of patients during hospitalization and after discharge has been developed. The Readiness for Hospital
Discharge after Myocardial Infarction Scale (RHD-MIS) was designed for in-hospital evaluation, while the
Adherence in Chronic Diseases Scale (ACDS) and the Functioning in Chronic Illness Scale (FCIS) for
examination during follow-up visits. They are expected to reflect the effectiveness of different aspects of
patient-medical staff collaboration. Use of questionnaires seems to be a method of choice for this purpose
because of the simplicity, easiness of their application, and low cost. Self-reported questionnaires allow
comprehensive in-hospital and post-discharge assessment of patients after ACS.
Abstract
Effective patients’ preparation for discharge is expected to improve adherence to long-term treatment and
functioning in chronic faze of coronary artery disease-ameliorating clinical outcome. This paper is aimed to
introduce the strategy of comprehensive post-ACS in-hospital patients’ evaluation regarding readiness for
hospital discharge, as well as a post-discharge assessment of adherence to pharmacological treatment and
functioning in the chronic phase of the coronary artery. A system of diagnostic tools allowing assessment
of patients during hospitalization and after discharge has been developed. The Readiness for Hospital
Discharge after Myocardial Infarction Scale (RHD-MIS) was designed for in-hospital evaluation, while the
Adherence in Chronic Diseases Scale (ACDS) and the Functioning in Chronic Illness Scale (FCIS) for
examination during follow-up visits. They are expected to reflect the effectiveness of different aspects of
patient-medical staff collaboration. Use of questionnaires seems to be a method of choice for this purpose
because of the simplicity, easiness of their application, and low cost. Self-reported questionnaires allow
comprehensive in-hospital and post-discharge assessment of patients after ACS.
Keywords
self-reported questionnaire, adherence to treatment, coronary artery disease
About this articleTitle
Self-reported questionnaires for a comprehensive assessment of patients after acute coronary syndrome
Journal
Issue
Article type
Review article
Pages
106-109
Published online
2019-04-17
Page views
3342
Article views/downloads
1260
DOI
Bibliographic record
Medical Research Journal 2019;4(2):106-109.
Keywords
self-reported questionnaire
adherence to treatment
coronary artery disease
Authors
Aldona Kubica
References (42)- Kubica A, Kochman W, Bogdan M, et al. The influence of undergone percutaneous coronary interventions, and earlier hospitalizations with myocardial infarction on the level of knowledge and the effectiveness of health education in patients with myocardial infarction. Advances in Interventional Cardiology. 2009; 5: 25–30.
- DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004; 42(3): 200–209.
- Kubica A. Współpraca z pacjentem – podstawowy warunek skuteczności terapii w chorobie wieńcowej. Choroby Serca i Naczyń. 2009; 6: 131.
- Michalski P, Kosobucka A, Pietrzykowski Ł, et al. Knowledge and learning preferences of patients with myocardial infarction. Medical Research Journal. 2017; 1(4): 120–124.
- Michalski P, Kosobucka A, Pietrzykowski Ł, et al. Effectiveness of therapeutic education in patients with myocardial infarction. Medical Research Journal. 2018; 2(3): 89–96.
- Kubica A, Obońska K, Fabiszak T, et al. Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials. Curr Med Res Opin. 2016; 32(8): 1441–1451.
- Buszko K, Kosobucka A, Michalski P, et al. The readiness for hospital discharge of patients after acute myocardial infarction: a new self-reported questionnaire. Medical Research Journal. 2017; 2(1): 20–28.
- Patel H, Mourad M. Demystifying discharge: Assessing discharge readiness to predict day of discharge. J Hosp Med. 2015; 10(12): 832–833.
- Pietrzykowski Ł, Michalski P, Kosobucka A, et al. Knowledge about health and disease in obese patients after myocardial infarction. An observational study. Medical Research Journal. 2018; 2(4): 135–140.
- Kubica A, Gruchała M, Jaguszewski M, et al. Adherence to treatment — a pivotal issue in long-term treatment of patients with cardiovascular diseases. An expert standpoint. Medical Research Journal. 2018; 2(4): 123–127.
- Kubica A, Kasprzak M, Obońska K, et al. Impact of health education on adherence to clopidogrel and clinical effectiveness of antiplatelet treatment in patients after myocardial infarction. Medical Research Journal. 2016; 3(4): 154–159.
- Jankowski P, Czarnecka D, Łukaszewska A, et al. Factors related to the effectiveness of hypercholesterolemia treatment following hospitalization for coronary artery disease. Pol Arch Med Wewn. 2016; 126(6): 388–394.
- Kubica A, Obońska K, Fabiszak T, et al. Adherence to antiplatelet treatment with P2Y12 receptor inhibitors. Is there anything we can do to improve it? A systematic review of randomized trials. Curr Med Res Opin. 2016; 32(8): 1441–1451.
- Kubica A, Kasprzak M, Obońska K, et al. Discrepancies in assessment of adherence to antiplatelet treatment after myocardial infarction. Pharmacology. 2015; 95(1-2): 50–58.
- Kubica A, Kasprzak M, Siller-Matula J, et al. Time-related changes in determinants of antiplatelet effect of clopidogrel in patients after myocardial infarction. Eur J Pharmacol. 2014; 742: 47–54.
- Buszko K, Obońska K, Michalski P, et al. The Adherence Scale in Chronic Diseases (ASCD). The power of knowledge: the key to successful patient — health care provider cooperation. Medical Research Journal. 2016; 1(1): 37–42.
- Kubica A, Kosobucka A, Michalski P, et al. The Adherence in Chronic Diseases Scale — a new tool to monitor implementation of a treatment plan. Folia Cardiol. 2017; 12: 19–26.
- Buszko K, Pietrzykowski Ł, Michalski P, et al. Validation of the Functioning in Chronic Illness Scale (FCIS). Medical Research Journal. 2018; 3(2): 63–69.
- Galvin EC, Wills T, Coffey A. Readiness for hospital discharge: A concept analysis. J Adv Nurs. 2017; 73(11): 2547–2557.
- Weiss ME, Costa LL, Yakusheva O, et al. Validation of patient and nurse short forms of the Readiness for Hospital Discharge Scale and their relationship to return to the hospital. Health Serv Res. 2014; 49(1): 304–317.
- van Galen LS, Brabrand M, Cooksley T, et al. Safer@home consortium. Patients' and providers' perceptions of the preventability of hospital readmission: a prospective, observational study in four European countries. BMJ Qual Saf. 2017; 26(12): 958–969.
- Potkin SG, Gharabawi GM, Greenspan AJ, et al. Psychometric evaluation of the Readiness for Discharge Questionnaire. Schizophr Res. 2005; 80(2-3): 203–212.
- Kubica A, Obońska K, Kasprzak M, et al. Prediction of high risk of non-adherence to antiplatelet treatment. Kardiol Pol. 2016; 74(1): 61–67.
- Sabate E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization, 2003. http://www.who.int/chronic_conditions/en/adherence_report.pdf.
- Novak Sarotar B, Lainscak M. Psychocardiology in the elderly. Wien Klin Wochenschr. 2016; 128(Suppl 7): 474–479.
- O'Neil A, Stevenson CE, Williams ED, et al. The health-related quality of life burden of co-morbid cardiovascular disease and major depressive disorder in Australia: findings from a population-based, cross-sectional study. Qual Life Res. 2013; 22(1): 37–44.
- Kunschitz E, Friedrich O, Schöppl C, et al. Assessment of the need for psychosomatic care in patients with suspected cardiac disease. Wien Klin Wochenschr. 2017; 129(7-8): 225–232.
- Romera I, Perez V, Menchón JM, et al. Social and occupational functioning impairment in patients in partial versus complete remission of a major depressive disorder episode. A six-month prospective epidemiological study. Eur Psychiatry. 2010; 25(1): 58–65.
- Burström M, Brännström M, Boman K, et al. Life experiences of security and insecurity among women with chronic heart failure. J Adv Nurs. 2012; 68(4): 816–825.
- Alla F, Briançon S, Guillemin F, et al. EPICAL Investigators. Self-rating of quality of life provides additional prognostic information in heart failure. Insights into the EPICAL study. Eur J Heart Fail. 2002; 4(3): 337–343.
- Pedrosa H, Sa ADe, Guerreiro M, et al. Functional evaluation distinguishes MCI patients from healthy elderly people — The ADCS/MCI/ADL scale. The journal of nutrition, health & aging. 2010; 14(8): 703–709.
- Basinska MA, Andruszkiewicz A. Health locus of control in patients with graves-basedow disease and hashimoto disease and their acceptance of illness. Int J Endocrinol Metab. 2012; 10(3): 537–542.
- Kosobucka A, Michalski P, Pietrzykowski Ł, et al. Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction. Patient Prefer Adherence. 2018; 12: 333–340.
- Kubica J, Adamski P, Buszko K, et al. Rationale and Design of the Effectiveness of LowEr maintenanCe dose of TicagRelor early After myocardial infarction (ELECTRA) pilot study. Eur Heart J Cardiovasc Pharmacother. 2018; 4(3): 152–157.
- Kubica J, Adamski P, Buszko K, et al. Platelet inhibition with standard versus lower maintenance dose of ticagrelor early after myocardial infarction (ELECTRA): a randomized, open-label, active-controlled pharmacodynamic and pharmacokinetic study. Eur Heart J Cardiovasc Pharmacother. 2019 [Epub ahead of print].
- Kosobucka A, Kasprzak M, Michalski P, et al. Relation of the Readiness for Hospital Discharge after Myocardial Infarction Scale to socio-demographic and clinical factors. An observational study. Medical Research Journal. 2018; 3(1): 32–37.
- Kubica A, Kozinski M, Grzesk G, et al. Genetic determinants of platelet response to clopidogrel. J Thromb Thrombolysis. 2011; 32(4): 459–466.
- Kubica A, Koziński M, Grześk G, et al. [Clinical significance of interactions between clopidogrel and proton pump inhibitors]. Kardiol Pol. 2011; 69(6): 610–616.
- Stolarek W, Kasprzak M, Obońska K, et al. Acetylsalicylic acid resistance risk factors in patients with myocardial infarction. Pharmacol Rep. 2015; 67(5): 952–958.
- Frost MH, Reeve BB, Liepa AM, et al. Mayo/FDA Patient-Reported Outcomes Consensus Meeting Group;. What is sufficient evidence for the reliability and validity of patient-reported outcome measures? Value Health. 2007; 10 Suppl 2: S94–S9S105.
- Krousel-Wood M, Muntner P, Jannu A, et al. Reliability of a medication adherence measure in an outpatient setting. Am J Med Sci. 2005; 330(3): 128–133.
- Kosobucka A, Michalski P, Pietrzykowski Ł, et al. Adherence to treatment assessed with the Adherence in Chronic Diseases Scale in patients after myocardial infarction. Patient Prefer Adherence. 2018; 12: 333–340.